AUKELSO
NDC 83257-030, Denosumab-kyqq, injection, from Biocon Biologics Inc..
- Product NDC
- 83257-030
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761436
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DENOSUMAB120 mg/1.7mL
Pharmacologic classes
RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-030-11 | 83257003011 | 1 VIAL, SINGLE-USE in 1 CARTON (83257-030-11) / 1.7 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/547cb095-f7f5-f933-75ce-5e6abf2ad5bcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83257-030
Use it
Look up 83257-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.